Orion Biotech Opportunities Common Stock

As of the most recent data (December 2022), ORIA shows a common stock of $200M. That compares with $400M in the prior-year period — down 49.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ORIA's common stock is now $200M (was $400M) — a 49.5% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Orion Biotech Opportunities is outperforming or lagging.

Tracking ORIA's common stock over time shows whether Orion Biotech Opportunities is scaling, shrinking, or reshaping that part of the business. The current reading is $200M That compares with $400M in the prior-year period — down 49.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this common stock page, Stockcircle has Orion Biotech Opportunities's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect common stock (currently $200M) with ownership activity and broader fundamentals.